Tyler Forness with producer Dave Stefano on Vikings 1st & SKOL dive into the salary cap strategy that could mirror the ...

The global caryophyllene market is projected to grow at a CAGR of 6.5%, reaching USD 923.4 million by 2035. Pharmaceuticals ...

The best fake plants both look real and are built to last. Check out our top picks for the best fake plants from Nearly ...

Promising Systemic Sclerosis Pipeline Therapies such as Divozilimab, Avenciguat (BI 685509), Nintedanib, GSK2330811, Riociguat (Adempas, BAY63-2521), Bosentan, Imatinib mesylate, Belimumab, Rituximab, ...

CB2 enters into binding Letter of Intent to acquire APEX Family Medical. APEX generated over CAD 2.5 million in revenues in fiscal 2019 and CAD 0.5 million in net income. Currently services over 5,000 ...

TORONTO, Oct. 29, 2020 /CNW/ - CB2 Insights (CSE:CBII) (OTCQB: CBIIF) ("CB2" or the "Company") is pleased to announce that it has amended the terms of its previously announced offering of Common ...

CB2 Insights (OTCQB:CBIIF -2.9%) intends to complete a non-brokered private placement of up to 20M units at a price of $0.15 per unit.Each unit consists of one common share and one half of ...

Galassini brings more than 20 years of experience in the Insurance and Payor industry as a former Medco Health Solutions, Inc executive Galassini will help drive growth for CB2 in developing a sales ...

--CB2 Insights Inc. announces that it has been delayed in filing its annual financial statements and associated management discussion and analysis for the year-ended December 31, 2019, which were ...

This month, we saw the CB2 Insights Inc. (CSE:CBII) up an impressive 80%. But that isn't much consolation to those who have suffered through the declines of the last year. During that time the ...

CB2 Insights Inc (CSE:CBII) (OTMKTS:CBIIF), the cannabis research and education group, unveiled director changes on Wednesday, including the appointment of... This website uses cookies. We use cookies ...